F. Wolfhagen

Management of osteoporosis in primary biliary cirrhosis.

F. Vleggaar, H. V. van Buuren, S. Schalm, 2000, Bailliere's best practice & research. Clinical gastroenterology.

Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.

W. Hop, H. V. van Buuren, M. Bertolotti, 1997, Gastroenterology.

Severe nausea and vomiting with timolol eye drops

R. Ouwendijk, F. Wolfhagen, J. V. Neerven, 1998, The Lancet.

Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.

F. T. ten Kate, G. P. van Berge‐Henegouwen, H. V. van Buuren, 1998, Journal of hepatology.

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.

W. Hop, F. T. ten Kate, H. V. van Buuren, 1998, Journal of hepatology.

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.

W. Hop, H. Pols, J. V. van Leeuwen, 1997, Journal of hepatology.

Prospective Risk Assessment of Endoscopic Retrograde Cholangiography in Patients with Primary Sclerosing Cholangitis

H. V. van Buuren, D. V. van Leeuwen, D. J. Leeuwen, 2000, Endoscopy.